Literature DB >> 22498751

Drug development risk and the cost of capital.

Aris I Baras, Alex S Baras, Kevin A Schulman.   

Abstract

Mesh：

Year:  2012        PMID： 22498751     DOI： 10.1038/nrd3722

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  2 in total

1.  The price of innovation: new estimates of drug development costs.

Authors:  Joseph A DiMasi; Ronald W Hansen; Henry G Grabowski
Journal:  J Health Econ       Date:  2003-03       Impact factor: 3.883

2.  The valuation high ground.

Authors:  Jeffrey J Stewart; Ben Bonifant
Journal:  Nat Biotechnol       Date:  2009-11       Impact factor: 54.908
  2 in total
  2 in total

1.  The Expected Net Present Value of Developing Weight Management Drugs in the Context of Drug Safety Litigation.

Authors:  Anita Chawla; Ginger Carls; Edmund Deng; Edward Tuttle
Journal:  Pharmacoeconomics       Date:  2015-07       Impact factor: 4.981

2.  A novel lab-on-a-chip platform for spheroid metabolism monitoring.

Authors:  Frank Alexander; Sebastian Eggert; Joachim Wiest
Journal:  Cytotechnology       Date:  2017-10-14       Impact factor: 2.058
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.